Workflow
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics, Inc.
KYTXKyverna Therapeutics(KYTX) ACCESSWIRE Newsroom·2025-01-20 23:30

公司相关 - Schall Law Firm 邀请遭受损失的股东加入针对 Kyverna Therapeutics, Inc. 的证券欺诈案件 [1] 行业相关 - 该案件涉及证券欺诈 表明生物技术行业可能存在信息披露或合规性问题 [1]